Navigation Links
Type 1 diabetes research at UC San Diego gets $5 million boost
Date:9/27/2010

Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes. Sander will lead a team of domestic and international collaborators, with the aim of generating replacement insulin-producing beta cells from patient-derived induced pluripotent stem cells.

The $4,950,000 grant is shared with Karl Willert, PhD, director of the UCSD Human Stem Cell Core Facility, who will apply a screening platform for cellular microenvironments to beta cell differentiation (the process by which cells become progressively more specialized.) Additional participants include labs at the University of Pennsylvania and in Barcelona, Spain, as well as a San Diego-based biotech company.

Sander is a physician-scientist with UCSD's Pediatric Diabetes Research Center (PDRC). Launched the summer of 2008, the PDRC brings together top-ranked physicians and research scientists to investigate the causes and cure of type 1 diabetes.

Type 1 diabetes can occur at any age; however, half of the patients are diagnosed before the age of 20. Though the exact cause is unknown, genetics, viruses, and environmental factors are thought to play a role in causing the autoimmune response that eventually leads to beta cell destruction.

The major focus of Sander's current research is to understand the molecular mechanisms underlying the ability of pluripotent stem cells, or progenitor cells, to produce the different cell types of the pancreas. Specifically, she and her team want to be able to instruct patient-derived pluripotent stem cells to become beta cells.

Since the first pioneering work on islet transplantation, it has become clear that a cell-based approach for the treatment of type 1 diabetes can have significant benefits in terms of insulin independence and a reduced risk of hypoglycemia.

"Right now, scientists can create pancreatic progenitor cells from human embryonic stem cells. However, our goal is to take it a step further and make replacement beta cells from the patient's own tissue," Sander said. "This grant is a perfect example of collaboration and translational medicine for a greater cause. It's not about who discovers the cure first. It's about finding a cure fast."


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California -- San Diego
Source:Eurekalert  

Related medicine news :

1. OHSU research team joins elite consortium dedicated to curing type 1 diabetes
2. Congressman to speak at meeting on diabetes and obesity
3. Drug holds promise to halt debilitating condition of diabetes
4. Immune System Genes Show Links to Type 1 Diabetes
5. Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice
6. New study singles out factors linked to cognitive deficits in type 2 diabetes
7. Moms who dont breastfeed more likely to develop type 2 diabetes
8. Diabetes impairs but does not halt sex among older adults
9. Link Between Diabetes, Alzheimers Disease Strengthened
10. Heart Risks the Same With 2 Diabetes Drugs: Study
11. Fat distribution plays a role in weight loss success in patients at risk of diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Type 1 diabetes research at UC San Diego gets $5 million boost
(Date:12/2/2016)... ... 02, 2016 , ... The PAINWeekEnd Regional Conference will be ... in Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing ... for supplemental training related to pain management has surged dramatically in recent years, ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... Rijuven ... stress and overall health, day and night. No other wearable health technology on the ... We wanted to give poeple more meaningful insights about their health than the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... Laboratory Scientist & Author of Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health radio ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... INDIANAPOLIS , Dec. 2, 2016  Eli Lilly ... its financial guidance for 2017 and provide updated financial ... will also conduct a conference call on that day ... the company,s financial guidance. The conference call ... the general public can access a live webcast of ...
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... Research and Markets has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. ... , , Drug delivery ... value of drug delivery technologies and the anticancer drugs are difficult ... organs involved and the types of cancer as well as according ...
Breaking Medicine Technology: